Patient: Description of condition (onset, main symptoms, hospital visited, etc.): April 10, 2011 surgery, in Xinzhou, Shanxi, lymph nodes have not metastasized, plus a stabilizer and occluder, please teach the late treatment plan. Doctor’s reply: Hello! Surgery is the main treatment for pancreatic cancer of the fundus, it accounts for 7-8% of the whole treatment, the rest of the things, should be a comprehensive treatment process mainly chemotherapy, but it depends on the details of your postoperative pathology, that is, the clinical stage, whether you need chemotherapy, which needs to be determined by the doctor. Patients: 1, is it appropriate to do chemotherapy at the age of 74, the body is thin. 2.Is it better to take oral chemotherapy drugs or infusion chemotherapy Doctor’s reply: 1.As for postoperative treatment of gastric cancer, generally speaking, systemic chemotherapy is no longer advocated above 70 years old. At present, the whole population in China is aging, and many people thought 10 years ago that the risk of surgery for 60-year-olds is already very high, but now some of us are still doing surgery for 90-year-olds. Why? Individualized judgment. The general principle of chemotherapy: it must do more good than harm. Chemotherapy is a double-edged sword. If the patient cannot eat, lose weight, etc. after receiving chemotherapy, the body is broken and the immunity is reduced, even if chemotherapy works to kill 99% of the cancer cells, the remaining 1% will resurface in a very short time. On the contrary, if you are more than 70 years old and after chemotherapy, the reaction is mild and the overall condition of the person is better (weight gain, better mental state, etc.), then chemotherapy is helping the post-operative patient to further kill the cancer cells, which is beneficial. So, according to your actual situation, individualized decision. 2. Purely in terms of efficacy, the effect of oral chemotherapy is not as good as that of infusion chemotherapy. However, it depends on the patient’s tolerance. If the patient cannot tolerate the infusion chemotherapy, oral should be an option.